Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience ...
A proof-of-concept trial by researchers at ETH Zurich, the University Hospitals of Basel and Zurich, and the Basel-Land Cantonal Hospital, demonstrated that treating breast cancer patients with a low, ...
Irregular heartbeat conditions affect millions of people worldwide, causing hearts to beat too fast, too slow, or with an uneven rhythm. These cardiac rhythm disturbances, medically known as ...
Cardiac glycosides derived from the foxglove plant have been used in cardiology for two centuries, but digoxin and digitoxin have gradually fallen out of favor and are now considered controversial in ...
MADRID, Spain—Adding digitoxin, a cardiac glycoside, to contemporary guideline-directed medical therapy (GDMT) improves clinical outcomes in patients who have heart failure with reduced ejection ...
Objective:To identify the frequency of atrioventricular (AV) conduction improvement after discontinuation of the culprit drug in patients with AV block. Background:AV blockers are considered as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results